Report cover image

Global Corticosteroids Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 191 Pages
SKU # APRC20556764

Description

Summary

According to APO Research, the global Corticosteroids market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Corticosteroids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Corticosteroids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Corticosteroids market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Corticosteroids is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Corticosteroids market include Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, AstraZeneca, Sumitomo and Cipla, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Corticosteroids, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Corticosteroids, also provides the sales of main regions and countries. Of the upcoming market potential for Corticosteroids, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Corticosteroids sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Corticosteroids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Corticosteroids sales, projected growth trends, production technology, application and end-user industry.

Corticosteroids Segment by Company

Sanofi
Johnson & Johnson
Novartis
Merck
Pfizer
GlaxoSmithKline
AstraZeneca
Sumitomo
Cipla
Corticosteroids Segment by Type

Cream
Injection
Other
Corticosteroids Segment by Application

Dermatology
Endocrinology
Allergy
Other
Corticosteroids Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Corticosteroids status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Corticosteroids market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Corticosteroids significant trends, drivers, influence factors in global and regions.
6. To analyze Corticosteroids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corticosteroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Corticosteroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corticosteroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Corticosteroids market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Corticosteroids industry.
Chapter 3: Detailed analysis of Corticosteroids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Corticosteroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Corticosteroids in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Corticosteroids Sales Value (2020-2031)
1.2.2 Global Corticosteroids Sales Volume (2020-2031)
1.2.3 Global Corticosteroids Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Corticosteroids Market Dynamics
2.1 Corticosteroids Industry Trends
2.2 Corticosteroids Industry Drivers
2.3 Corticosteroids Industry Opportunities and Challenges
2.4 Corticosteroids Industry Restraints
3 Corticosteroids Market by Company
3.1 Global Corticosteroids Company Revenue Ranking in 2024
3.2 Global Corticosteroids Revenue by Company (2020-2025)
3.3 Global Corticosteroids Sales Volume by Company (2020-2025)
3.4 Global Corticosteroids Average Price by Company (2020-2025)
3.5 Global Corticosteroids Company Ranking (2023-2025)
3.6 Global Corticosteroids Company Manufacturing Base and Headquarters
3.7 Global Corticosteroids Company Product Type and Application
3.8 Global Corticosteroids Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Corticosteroids Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Corticosteroids Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Corticosteroids Market by Type
4.1 Corticosteroids Type Introduction
4.1.1 Cream
4.1.2 Injection
4.1.3 Other
4.2 Global Corticosteroids Sales Volume by Type
4.2.1 Global Corticosteroids Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Corticosteroids Sales Volume by Type (2020-2031)
4.2.3 Global Corticosteroids Sales Volume Share by Type (2020-2031)
4.3 Global Corticosteroids Sales Value by Type
4.3.1 Global Corticosteroids Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Corticosteroids Sales Value by Type (2020-2031)
4.3.3 Global Corticosteroids Sales Value Share by Type (2020-2031)
5 Corticosteroids Market by Application
5.1 Corticosteroids Application Introduction
5.1.1 Dermatology
5.1.2 Endocrinology
5.1.3 Allergy
5.1.4 Other
5.2 Global Corticosteroids Sales Volume by Application
5.2.1 Global Corticosteroids Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Corticosteroids Sales Volume by Application (2020-2031)
5.2.3 Global Corticosteroids Sales Volume Share by Application (2020-2031)
5.3 Global Corticosteroids Sales Value by Application
5.3.1 Global Corticosteroids Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Corticosteroids Sales Value by Application (2020-2031)
5.3.3 Global Corticosteroids Sales Value Share by Application (2020-2031)
6 Corticosteroids Regional Sales and Value Analysis
6.1 Global Corticosteroids Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Corticosteroids Sales by Region (2020-2031)
6.2.1 Global Corticosteroids Sales by Region: 2020-2025
6.2.2 Global Corticosteroids Sales by Region (2026-2031)
6.3 Global Corticosteroids Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Corticosteroids Sales Value by Region (2020-2031)
6.4.1 Global Corticosteroids Sales Value by Region: 2020-2025
6.4.2 Global Corticosteroids Sales Value by Region (2026-2031)
6.5 Global Corticosteroids Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Corticosteroids Sales Value (2020-2031)
6.6.2 North America Corticosteroids Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Corticosteroids Sales Value (2020-2031)
6.7.2 Europe Corticosteroids Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Corticosteroids Sales Value (2020-2031)
6.8.2 Asia-Pacific Corticosteroids Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Corticosteroids Sales Value (2020-2031)
6.9.2 South America Corticosteroids Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Corticosteroids Sales Value (2020-2031)
6.10.2 Middle East & Africa Corticosteroids Sales Value Share by Country, 2024 VS 2031
7 Corticosteroids Country-level Sales and Value Analysis
7.1 Global Corticosteroids Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Corticosteroids Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Corticosteroids Sales by Country (2020-2031)
7.3.1 Global Corticosteroids Sales by Country (2020-2025)
7.3.2 Global Corticosteroids Sales by Country (2026-2031)
7.4 Global Corticosteroids Sales Value by Country (2020-2031)
7.4.1 Global Corticosteroids Sales Value by Country (2020-2025)
7.4.2 Global Corticosteroids Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Corticosteroids Sales Value Growth Rate (2020-2031)
7.5.2 USA Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Corticosteroids Sales Value Growth Rate (2020-2031)
7.6.2 Canada Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Corticosteroids Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Corticosteroids Sales Value Growth Rate (2020-2031)
7.8.2 Germany Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Corticosteroids Sales Value Growth Rate (2020-2031)
7.9.2 France Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.9.3 France Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Corticosteroids Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Corticosteroids Sales Value Growth Rate (2020-2031)
7.11.2 Italy Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Corticosteroids Sales Value Growth Rate (2020-2031)
7.12.2 Spain Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Corticosteroids Sales Value Growth Rate (2020-2031)
7.13.2 Russia Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Corticosteroids Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Corticosteroids Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Corticosteroids Sales Value Growth Rate (2020-2031)
7.16.2 China Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.16.3 China Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Corticosteroids Sales Value Growth Rate (2020-2031)
7.17.2 Japan Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Corticosteroids Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Corticosteroids Sales Value Growth Rate (2020-2031)
7.19.2 India Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.19.3 India Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Corticosteroids Sales Value Growth Rate (2020-2031)
7.20.2 Australia Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Corticosteroids Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Corticosteroids Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Corticosteroids Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Corticosteroids Sales Value Growth Rate (2020-2031)
7.24.2 Chile Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Corticosteroids Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Corticosteroids Sales Value Growth Rate (2020-2031)
7.26.2 Peru Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Corticosteroids Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Corticosteroids Sales Value Growth Rate (2020-2031)
7.28.2 Israel Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Corticosteroids Sales Value Growth Rate (2020-2031)
7.29.2 UAE Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Corticosteroids Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Corticosteroids Sales Value Growth Rate (2020-2031)
7.31.2 Iran Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Corticosteroids Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Corticosteroids Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Corticosteroids Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Corticosteroids Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.1.4 Sanofi Corticosteroids Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Corticosteroids Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.3.4 Novartis Corticosteroids Product Portfolio
8.3.5 Novartis Recent Developments
8.4 Merck
8.4.1 Merck Comapny Information
8.4.2 Merck Business Overview
8.4.3 Merck Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.4.4 Merck Corticosteroids Product Portfolio
8.4.5 Merck Recent Developments
8.5 Pfizer
8.5.1 Pfizer Comapny Information
8.5.2 Pfizer Business Overview
8.5.3 Pfizer Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.5.4 Pfizer Corticosteroids Product Portfolio
8.5.5 Pfizer Recent Developments
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Comapny Information
8.6.2 GlaxoSmithKline Business Overview
8.6.3 GlaxoSmithKline Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.6.4 GlaxoSmithKline Corticosteroids Product Portfolio
8.6.5 GlaxoSmithKline Recent Developments
8.7 AstraZeneca
8.7.1 AstraZeneca Comapny Information
8.7.2 AstraZeneca Business Overview
8.7.3 AstraZeneca Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.7.4 AstraZeneca Corticosteroids Product Portfolio
8.7.5 AstraZeneca Recent Developments
8.8 Sumitomo
8.8.1 Sumitomo Comapny Information
8.8.2 Sumitomo Business Overview
8.8.3 Sumitomo Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.8.4 Sumitomo Corticosteroids Product Portfolio
8.8.5 Sumitomo Recent Developments
8.9 Cipla
8.9.1 Cipla Comapny Information
8.9.2 Cipla Business Overview
8.9.3 Cipla Corticosteroids Sales, Value and Gross Margin (2020-2025)
8.9.4 Cipla Corticosteroids Product Portfolio
8.9.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Corticosteroids Value Chain Analysis
9.1.1 Corticosteroids Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Corticosteroids Sales Mode & Process
9.2 Corticosteroids Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Corticosteroids Distributors
9.2.3 Corticosteroids Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.